A biotechnology company focused on developing and licensing drug discovery technologies and capturing royalty streams from partnered medicines. Its platforms and intellectual property are used by pharmaceutical and biotech partners to develop therapies, generating milestone payments and ongoing roya...
No congressional trades have been disclosed for ligand Pharmaceuticals (LIPH) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
No congressional trades found for this stock.